EMAIL THIS PAGE TO A FRIEND

Journal of medical toxicology : official journal of the American College of Medical Toxicology

The scientific basis for chelation: animal studies and lead chelation.


PMID 24113857

Abstract

This presentation summarizes several of the rodent and non-human studies that we have conducted to help inform the efficacy and clinical utility of succimer (meso-2,3-dimercaptosuccincinic acid) chelation treatment. We address the following questions: (1) What is the extent of body lead, and in particular brain lead reduction with chelation, and do reductions in blood lead accurately reflect reductions in brain lead? (2) Can succimer treatment alleviate the neurobehavioral impacts of lead poisoning? And (3) does succimer treatment, in the absence of lead poisoning, produce neurobehavioral deficits? Results from our studies in juvenile primates show that succimer treatment is effective at accelerating the elimination of lead from the body, but chelation was only marginally better than the complete cessation of lead exposure alone. Studies in lead-exposed adult primates treated with a single 19-day course of succimer showed that chelation did not measurably reduce brain lead levels compared to vehicle-treated controls. A follow-up study in rodents that underwent one or two 21-day courses of succimer treatment showed that chelation significantly reduced brain lead levels, and that two courses of succimer were significantly more efficacious at reducing brain lead levels than one. In both the primate and rodent studies, reductions in blood lead levels were a relatively poor predictor of reductions in brain lead levels. Our studies in rodents demonstrated that it is possible for succimer chelation therapy to alleviate certain types of lead-induced behavioral/cognitive dysfunction, suggesting that if a succimer treatment protocol that produced a substantial reduction of brain lead levels could be identified for humans, a functional benefit might be derived. Finally, we also found that succimer treatment produced lasting adverse neurobehavioral effects when administered to non-lead-exposed rodents, highlighting the potential risks of administering succimer or other metal-chelating agents to children who do not have elevated tissue lead levels. It is of significant concern that this type of therapy has been advocated for treating autism.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

391352
Lead, powder, −100 mesh, 99.95% trace metals basis
Pb
209708
Lead, powder, −325 mesh, ≥99% trace metals basis
Pb
695912
Lead, shot, 1-3 mm, 99.995% trace metals basis
Pb
396117
Lead, shot, <2 mm, 99.9% trace metals basis
Pb
265888
Lead, wire, diam. 1.0 mm, 99.99% trace metals basis
Pb
GF96512597
Lead, foil, 150x150mm, thickness 0.5mm, as rolled, 99.95%
Pb
GF74259793
Lead, foil, 150x150mm, thickness 1.0mm, as rolled, 99.5%
Pb
GF57430638
Lead, foil, 150x150mm, thickness 1.0mm, as rolled, 99.95%
Pb
GF63249419
Lead, foil, 150x150mm, thickness 2.0mm, as rolled, 99.95%
Pb
GF60047760
Lead, foil, 250x250mm, thickness 3.0mm, as rolled, 99.95%
Pb
GF05521160
Lead, foil, 25x25mm, thickness 0.125mm, as rolled, 99.95%
Pb
GF42741637
Lead, foil, 25x25mm, thickness 0.125mm, as rolled, 99.99+%
Pb
GF60380940
Lead, foil, 25x25mm, thickness 0.15mm, as rolled, 99.95%
Pb
GF85562994
Lead, foil, 25x25mm, thickness 0.1mm, as rolled, 99.95%
Pb
GF74435519
Lead, foil, 25x25mm, thickness 0.25mm, as rolled, 99.95%
Pb
GF10987757
Lead, foil, 25x25mm, thickness 0.25mm, as rolled, 99.99+%
Pb
GF03985724
Lead, foil, 25x25mm, thickness 0.55mm, as rolled, 99.999%
Pb
GF73081852
Lead, foil, 25x25mm, thickness 0.5mm, as rolled, 99.95%
Pb
GF68898188
Lead, foil, 25x25mm, thickness 0.5mm, as rolled, 99.99+%
Pb
GF90025129
Lead, foil, 25x25mm, thickness 1.0mm, as rolled, 99.5%
Pb
GF55764041
Lead, foil, 25x25mm, thickness 1.0mm, as rolled, 99.95%
Pb
GF85349346
Lead, foil, 25x25mm, thickness 1.0mm, as rolled, 99.99+%
Pb
GF70374810
Lead, foil, 25x25mm, thickness 1.5mm, as rolled, 99.99+%
Pb
GF22900766
Lead, foil, 25x25mm, thickness 3.0mm, as rolled, 99.99+%
Pb
GF36533505
Lead, foil, 300x300mm, thickness 0.125mm, as rolled, 99.95%
Pb
GF00434843
Lead, foil, 300x300mm, thickness 0.15mm, as rolled, 99.95%
Pb
GF87346806
Lead, foil, 300x300mm, thickness 0.1mm, as rolled, 99.95%
Pb
GF50662773
Lead, foil, 300x300mm, thickness 0.25mm, as rolled, 99.95%
Pb
GF98077898
Lead, foil, 1000x1000mm, thickness 0.5mm, as rolled, 99.95%
Pb
GF68213538
Lead, foil, 100x100mm, thickness 0.125mm, as rolled, 99.95%
Pb